These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 15057650)
21. Breast tumour angiogenesis. Fox SB; Generali DG; Harris AL Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723 [TBL] [Abstract][Full Text] [Related]
22. Angiogenesis: an organizing principle for drug discovery? Folkman J Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134 [TBL] [Abstract][Full Text] [Related]
25. The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies. Thompson WD; Li WW; Maragoudakis M J Pathol; 1999 Apr; 187(5):503-10. PubMed ID: 10398113 [TBL] [Abstract][Full Text] [Related]
27. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Ng EW; Shima DT; Calias P; Cunningham ET; Guyer DR; Adamis AP Nat Rev Drug Discov; 2006 Feb; 5(2):123-32. PubMed ID: 16518379 [TBL] [Abstract][Full Text] [Related]
28. The fight against cancer: the next round. Doherty M Drug Discov Today; 2004 Nov; 9(22):947-8. PubMed ID: 15539135 [No Abstract] [Full Text] [Related]
29. Anti-Vegf Therapy for Ocular Diseases: Present and Future. Campa C; Parodi MB Curr Drug Targets; 2020; 21(12):1158. PubMed ID: 32957867 [No Abstract] [Full Text] [Related]